NasdaqGM:NUAI
NasdaqGM:NUAIOil and Gas

Assessing New Era Energy & Digital (NUAI) Valuation Following Sustainability Initiatives and Texas Data Center Progress

On November 4, New Era Energy & Digital (NUAI) shared updates in its Q4 2025 investor presentation and unveiled strategic moves toward sustainability. The company detailed progress on its Texas Critical Data Centers project and emphasized efforts to improve power reliability. See our latest analysis for New Era Energy & Digital. Momentum has surged for New Era Energy & Digital, with a 1-month share price return of nearly 217% and a massive 1,366% rise over the last 90 days, following its...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf (DBD): Deep Discount to Fair Value Reinforces Optimistic Turnaround Narrative

Diebold Nixdorf (DBD) remains unprofitable, but losses have narrowed significantly over the last five years at an annual rate of 41%. The company is expected to grow earnings at 36.43% per year, with a return to profit forecast within three years. This pace is well above the broader market. Revenue growth is projected at a slower 3% per year, which may not excite those hunting for top-line acceleration. However, current valuation metrics like a 0.6x price-to-sales ratio and trading well below...
NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Myriad Genetics (MYGN): Losses Compound at 21.1% Annually, Undercutting Value Narrative

Myriad Genetics (MYGN) remains in the red, with losses having climbed at a 21.1% annualized rate over the past five years, and the company is expected to stay unprofitable for at least the next three years. While revenue is forecast to grow 4.5% per year, which is less than half the 10.5% broader US market expectation, shares currently trade at $6.58, below an estimated fair value of $9.83. Despite a low price-to-sales ratio of 0.7x, ongoing net losses and a slower revenue trajectory continue...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain (IRM) Margin Hit Reinforces Debate Over Long-Term Value Versus Profit Compression

Iron Mountain (IRM) posted a net profit margin of just 0.6% this period, slipping from 3.9% a year ago, as EPS fell sharply. Over the last twelve months, results took a hit from a one-off loss of $221.6 million, and earnings have declined at a painful rate of 21.3% per year over the past five years. With the stock trading at $100.47, investors are left weighing slower revenue growth forecasts of 8.6% per year against an expected 43.3% annual recovery in earnings over the next three years...
NasdaqCM:NEOV
NasdaqCM:NEOVElectrical

What NeoVolta (NEOV)'s Record Q1 2026 Revenue Guidance Means For Shareholders

NeoVolta Inc. recently provided revenue guidance for the first quarter of fiscal 2026, anticipating revenue of over US$6.5 million, a very large year-over-year increase and the company's fourth consecutive record-setting quarter, following US$8.4 million in total revenue for fiscal 2025. This projection represents NeoVolta’s highest quarterly revenue to date and highlights an accelerating growth trajectory in the company’s market positioning. We’ll explore how NeoVolta’s continued quarterly...
NYSE:SMRT
NYSE:SMRTElectronic

SmartRent (SMRT): Losses Narrow 5.7% Annually, But Profitability Remains Out of Reach

SmartRent (SMRT) remains unprofitable, but it has managed to reduce its losses at an average rate of 5.7% per year over the past five years. The stock trades at $1.40, trading above its estimated fair value of $0.52, and it posts a Price-to-Sales Ratio of 1.7x, which is lower than both its peer average of 5.4x and the US Electronic industry average of 2.6x. While profitability is still out of reach and net profit margins have not shown improvement, investors may look to narrowing losses and...
NYSE:TREX
NYSE:TREXBuilding

Trex (TREX) Profit Margin Decline Challenges Bullish Valuation Narrative Despite Forecasted Earnings Growth

Trex Company (TREX) is forecast to grow earnings by around 7% and revenues by 6.8% annually, both trailing the broader US market’s projected growth rates of 16% and 10.5%, respectively. The company’s net profit margin now stands at 16.5%, down from 21.1% last year. It has averaged annual earnings growth of 3% over the past five years and currently has no notable risks flagged. With the stock trading below estimated fair value and profit and revenue growth expectations still intact, investors...
NasdaqGM:AIP
NasdaqGM:AIPSoftware

Arteris (AIP) Valuation Premium Stands Out as Losses Worsen and Profitability Stalls

Arteris (AIP) remains in the red, with losses growing at an average rate of 27.1% per year over the past five years, and net profit margin showing no year-over-year improvement. Despite persistent unprofitability, revenue is expected to expand by 17.9% annually, well ahead of the broader US market’s 10.5% forecast. However, with a price-to-sales ratio of 10.7x, which is significantly more expensive than the industry’s 5.1x and peer average of 2.1x, and a current share price of $15.53 above an...
NasdaqGM:RPD
NasdaqGM:RPDSoftware

Rapid7 (RPD) Profit Margin Turns Positive, Reinforcing Bullish Narratives on Earnings Growth Versus Sales

Rapid7 (RPD) has shifted into profitability over the past five years, with earnings growing at an average of 26.2% annually according to recent filings. The firm’s net profit margin turned positive in the past year, and analysts are forecasting earnings to accelerate by 43.5% per year, outpacing the US market’s 16% average. Revenue growth is expected to moderate at 3.1% per year against a 10.5% market average. With a price-to-earnings ratio of 32.9x that trails peer and industry averages, and...
NasdaqGS:LAB
NasdaqGS:LABLife Sciences

Standard BioTools (LAB): Profitability Challenges Persist Despite Attractive Price-to-Sales Ratio

Standard BioTools (LAB) remains unprofitable, with net losses deepening at an average annual rate of 17.3% over the last five years. Revenue is forecast to grow by just 2.5% per year, which trails the broader US market’s average of 10.5%. Despite a comparatively attractive Price-to-Sales ratio of 2.5x versus industry peers, there is no sign of positive net profit margin or margin improvement. The company is expected to continue booking losses for at least the next three years. See our full...
NYSE:RNG
NYSE:RNGSoftware

Is RingCentral a Bargain After Share Price Drops 8% and New Cloud Partnerships?

Wondering if RingCentral is a bargain or a value trap? You are not alone. It is the perfect time to dig deeper into what the numbers say about this stock. While RingCentral’s share price recently lost 8.0% in just the past week and is still down 21.6% since January, these movements return it close to levels seen three years ago. This may indicate shifting sentiment about the company’s growth or risk profile. Recent headlines highlight ongoing efforts by RingCentral to expand its product...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS): Losses Worsen Despite 15.1% Revenue Growth, Challenging Bull Narratives

One Stop Systems (OSS) is forecasting revenue growth of 15.1% per year, outpacing the US market’s projected 10.5% annual increase. Despite this robust top-line outlook, the company remains unprofitable and has experienced annual net losses rising at a steep 69.1% rate over the past five years, with no meaningful improvement in net profit margins. As a result, investors find themselves weighing the prospect of strong revenue expansion against ongoing challenges in profitability and a...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Golar LNG (GLNG): Profitability Forecasts Test Premium Valuation Narrative Ahead of Earnings

Golar LNG (GLNG) remains unprofitable, but the company has managed to shrink its losses by 4.6% per year over the past five years. Looking ahead, analysts project annual earnings growth of 51.12%, with expectations for profitability within the next three years. However, the company’s revenue growth forecast of 7.1% per year is behind the broader US market rate of 10.5%. See our full analysis for Golar LNG. The next step is to see how these headline numbers compare to the widely followed...
NasdaqCM:RDNW
NasdaqCM:RDNWSpecialty Retail

RideNow Group (RDNW): Losses Deepen at 34.3% Pace, Margin Stagnation Pressures Market Narrative

RideNow Group (RDNW) posted another challenging set of numbers, with losses deepening at a rapid 34.3% annual rate over the past five years. While revenue is projected to grow at just 4.4% per year, slower than the US market's 10.5% pace, the company's net profit margin has shown no improvement over the last year and there is no indication of high-quality past earnings. Despite the stock trading at a Price-To-Sales ratio of 0.1x, which is well below industry and peer averages, the persistence...
NYSE:BUR
NYSE:BURDiversified Financial

Burford Capital (BUR) Net Margin Jumps to 54.6%, Reinforcing Bullish Growth Narratives

Burford Capital (NYSE:BUR) is expected to deliver standout growth this year, with revenue forecast to rise 17.6% annually and earnings projected to climb 28.1% each year, both well ahead of the broader US market averages. The company’s net profit margin has increased to 54.6% from last year’s 47.2%, supported by a strong five-year earnings growth rate of 37.7%. Trading at a Price-to-Earnings ratio of 8.6x, which is well below industry and peer averages, and currently priced at $9.47 versus an...
NasdaqGS:EGHT
NasdaqGS:EGHTSoftware

8x8 (EGHT): Loss Reduction Continues, but Persistent Unprofitability Challenges Value Narrative

8x8 (EGHT) remains unprofitable, but over the past five years, the company has steadily reduced its losses by 34.4% per year. Its valuation stands out in the crowded software space, trading at a Price-To-Sales Ratio of just 0.4x. This figure is significantly below both the peer average of 15.9x and the US software industry average of 5.1x. While this low multiple may attract value-oriented investors, the share price has displayed notable volatility recently, and the lack of accelerating...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Fortrea Holdings (FTRE) Losses Deepen 52.8% Annually, Undervaluation Sparks Value Debate

Fortrea Holdings (FTRE) remains unprofitable, with losses accelerating at a 52.8% annual rate over the past five years. Looking ahead, analysts expect the company to stay in the red for at least three more years, while revenue growth is projected at just 2.4% per year, lagging the US market’s 10.5%. Despite trading at a Price-to-Sales Ratio of 0.4x, which is well below industry and peer averages, the current share price of $11.95 sits significantly under the estimated fair value of $18.73...
NasdaqGS:KRNT
NasdaqGS:KRNTMachinery

Kornit Digital (KRNT) Losses Deepen for Fifth Year, Challenging Bullish Turnaround Narratives

Kornit Digital (NasdaqGS:KRNT) remains unprofitable this period, with losses having deepened at an average rate of 31.6% per year over the last five years. While revenue is projected to grow by 7.6% per year going forward, this pace lags behind the US market average of 10.5%, and profit margin has failed to show improvement. Shares are trading at $12.50, putting the Price-to-Sales multiple at 2.8x, which is well above peers and the broader machinery industry. Fair value is estimated at...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Atlanta Braves Holdings (BATR.K): Loss Reduction Outpaces Expectations But Revenue Growth Lags Market Narrative

Atlanta Braves Holdings (BATR.K) remains unprofitable but has managed to reduce its losses by 6.9% per year over the past five years. With earnings projected to grow at 61.05% annually and the turning point to profitability anticipated within three years, ongoing loss reduction and expected profit growth are now the key points for investors keeping an eye on the company's earnings trajectory. See our full analysis for Atlanta Braves Holdings. Next up, we will stack these headline results...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX): Five-Year Loss Acceleration Challenges Bulls Despite 30.1% Revenue Growth Forecast

Recursion Pharmaceuticals (RXRX) remains firmly in the red, with losses increasing at an average rate of 35.2% per year over the past five years and no improvement in net profit margin. Despite this, revenue is forecast to accelerate at an impressive 30.1% per year, outpacing the broader US market’s projected 10.5% annual growth. Investors are weighing strong top-line growth expectations against a persistent track record of operating losses, a premium price-to-sales ratio of 33.6x, and a...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade (LMND) Revenue Forecast Outpaces Market, Challenging Profitability and Valuation Narratives

Lemonade (LMND) is forecast to grow revenue at 27.1% per year, outpacing the US market average of 10.5% per year. Still, the company remains unprofitable, with losses increasing at a rate of 5.7% per year over the past five years and profitability not expected within the next three years. While investors may be drawn to the rapid growth potential, ongoing losses and lack of near-term profitability are likely to weigh on sentiment. See our full analysis for Lemonade. Next up, we will see how...
NYSE:HNGE
NYSE:HNGEHealthcare

Hinge Health (HNGE) Trades Below Fair Value Despite 13.6% Revenue Growth Forecast

Hinge Health (HNGE) is expected to see revenue grow at 13.6% per year, outpacing the broader US market’s 10.5% forecast. While the company is not yet profitable, earnings are projected to surge at an annual rate of 92.55%, with profitability likely within the next three years. Despite a lack of long-term trading history and recent share price volatility, investors may focus on the high growth potential as a key positive for Hinge Health. See our full analysis for Hinge Health. Next, we will...
NYSE:MEG
NYSE:MEGCommercial Services

Montrose Environmental Group (MEG): Losses Narrow, But Slower Revenue Growth Reinforces Market Skepticism

Montrose Environmental Group (MEG) is forecasting revenue growth of 5.5% per year, trailing the wider US market’s expected 10.5% pace. The company remains in the red, but it has trimmed annual losses by an average of 11.1% over the past five years. While profitability remains elusive, investors are weighing the steady narrowing of losses against slower sales expansion and a premium Price-To-Sales Ratio. See our full analysis for Montrose Environmental Group. Now, let’s see how these latest...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Net Profit Margin Decline Challenges Bullish Narratives

Accel Entertainment (ACEL) reported a net profit margin of 2.8%, down from last year’s 4.1%. Despite achieving an impressive annualized earnings growth rate of 28.9% over the last five years, earnings turned negative in the most recent year, halting positive profit momentum. With revenue projected to grow at 3.8% per year and a price-to-earnings ratio of 24.3x, which is above the US Hospitality industry average, the numbers paint a more cautious outlook, especially given the stock trades...